On non-biologic treatment clinical remission in adult-onset asthma: A 20-year cohort study in Taiwan
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
BACKGROUND: Research on asthma clinical remission has mainly focused on severe asthma with biologic therapy. This study aimed to determine the prevalence and predictors of clinical remission in patients with adult-onset asthma receiving non-biologic treatment. METHODS: Data were retrieved from the Chang Gung Research Database (CGRD), the largest electronic medical records-based database in Taiwan. A total of 14,935 patients diagnosed with asthma between 2002 and 2022 were screened. There were 8043 on-treatment patients enrolled. We defined on-treatment clinical remission as follows: (1) absence of symptoms (ACT score ≥20); (2) no use of systemic steroids; (3) no clinical exacerbation for at least 12 months. RESULTS: These patients were categorized according to clinical remission status: those who achieved clinical remission (n = 2185), and those who had persistent asthma (n = 5858). The on non-biologic treatment clinical remission rate of adult-onset asthma was 27.2 %. Factors associated with persistent asthma included female, smoking history, forced expiratory volume in 1 s
Fields of Study & Subjects
Asthma and respiratory diseases
Chronic Obstructive Pulmonary Disease (COPD) Research
Occupational exposure and asthma
Publication details
- Journal / source
- Allergology International
- Volume
- 75
- Issue
- 3
- Pages
- 419–425
- Publication date
- 1 April 2026
- Language
- EN